Location: | Oxford |
---|---|
Salary: | £38,674 to £46,913 per annum |
Hours: | Full Time |
Contract Type: | Fixed-Term/Contract |
Placed On: | 20th May 2025 |
---|---|
Closes: | 16th June 2025 |
Job Ref: | 179764 |
We are seeking a talented and motivated researcher to join the Mead Group to contribute to a major research programme, focused on understanding and preventing disease progression in myeloproliferative neoplasms (MPNs).
You will take a lead role in conducting wet lab experimentation, applying state-of-the-art single-cell multiomic approaches, including transcriptomic, genetic, and DNA methylation analyses to patient-derived samples and disease models. Working closely with a dynamic and multidisciplinary team of clinicians and scientists, they will help generate and interpret high-resolution datasets that reveal new insights into disease progression, with the ultimate aim of identifying novel biomarkers and therapeutic targets. This is a unique opportunity to work at the cutting edge of translational haematology, supported by world-class facilities, access to deeply phenotyped clinical cohorts, and a strong collaborative network.
You will hold a relevant PhD/DPhil, together with relevant knowledge in normal and malignant haematopoiesis research. Experience generating single cell genomics data, previous experience of contributing to high-impact publications/presentations and the ability to manage your own academic research and associated activities are essential.
The post is available fixed-term until 31 December, 2027, funded by Ludwig Cancer Research.
Applications for this vacancy are to be made online. You will be required to upload a CV and supporting statement as part of your online application.
The closing date for this position is 12:00 noon on Monday 16 June 2025.
Interviews will take place on Monday 7 July, 2025.
Type / Role:
Subject Area(s):
Location(s):